## MMC: Marsh & McLennan Companies, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 0.4% below STRENGTH zone (4.0-10.0%); PEG 1.86 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (43% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($181.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Assenagon Asset Management S.A. Sells 792,891 Shares of Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251224T040830 | Somewhat-Bearish | Relevance: 100%
- Assenagon Asset Management S.A. significantly reduced its stake in Marsh & McLennan Companies, Inc. by selling 792,891 shares in the third quarter, decreasing its holdings by 98.0%. Despite this, other institutions like Vanguard Group Inc. and Valeo Financial Advisors LLC increased their positions substantially, with institutional investors collectively owning 87.99% of the company. CEO John Q. Doyle also sold a notable number of shares, while analysts generally maintain a "Hold" rating with an average price target of $222.35.

**2. Cadinha & Co. LLC Sells 79,802 Shares of Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251228T101014 | Somewhat-Bearish | Relevance: 100%
- Cadinha & Co. LLC significantly reduced its stake in Marsh & McLennan Companies (NYSE:MMC) by selling 79,802 shares in Q3, representing a 96.5% cut. Additionally, CEO John Q. Doyle sold 21,079 shares, decreasing his ownership by 19.38%. The company has an average "Hold" rating from analysts with an average target price of $222.35.

**3. Carnegie Investment Counsel Lowers Holdings in Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251227T103829 | Neutral | Relevance: 100%
- Carnegie Investment Counsel reduced its stake in Marsh & McLennan Companies by 6.2% in Q3, selling 6,375 shares and ending the period with 97,020 shares valued at $19.55 million. Meanwhile, other large institutional investors like Jennison Associates and Vanguard increased their holdings significantly. CEO John Q. Doyle also sold a portion of his shares, while analysts generally have a "Hold" rating on the stock with a consensus target price of $222.35.

**4. Fulton Breakefield Broenniman LLC Sells 56,878 Shares of Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251227T100829 | Neutral | Relevance: 97%
- Fulton Breakefield Broenniman LLC has significantly reduced its stake in Marsh & McLennan Companies (NYSE:MMC) by selling 56,878 shares, decreasing its holdings by 86.6% to 8,832 shares valued at approximately $1.78 million. This comes as CEO John Q. Doyle also sold a substantial portion of his shares, contributing to a 19.38% reduction in his direct ownership. Despite these sales, Marsh & McLennan recently surpassed Q3 earnings estimates and analysts currently rate the stock as a "Hold" with an average target price of $222.35.

**5. How Brown & Brownâ€™s (BRO) Acquisition-Fueled Q3 2025 Earnings Beat Has Changed Its Investment Story**
- Source: Simply Wall Street | 20251225T100840 | Neutral | Relevance: 64%
- Brown & Brown's Q3 2025 results surpassed market expectations, with revenue up 35.4% and EPS beating estimates by 12.9%, primarily driven by acquisitions and profit-sharing. This performance reinforces the success of its acquisition-led expansion strategy despite cyclical insurance and economic conditions. The company's investment narrative now centers on continued integration and execution of recent acquisitions, with future projections aiming for significant revenue and earnings growth by 2028.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $212 | $0 | 0% |
| 2025-12-04 | Citigroup | $201 | $211 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Outperform |
| 2025-12-04 | Citigroup | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.28M) |
| Sells | 1 ($3.84M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.1%)
- Blackrock Inc.: 7.9% (-3.7%)
- State Street Corpora: 4.4% (+0.4%)
- Capital Internationa: 3.8% (+1.2%)
- Capital World Invest: 3.6% (+0.5%)

### Key Risks

1. Insider selling cluster: $3.8M in recent transactions.
2. Long-term trend broken: trading 10.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- M&A activity or partnership announcements may unlock value.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.86 elevated, pricing in significant growth expectations. Forward P/E 18.1x stretched relative to 7% growth. Quality metrics strong (ROE 29%, margin 16%). Balance sheet: $2.3B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($3.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $91.9B |
| Beta | 0.75 |
| 52W Range | $174.18 - $248.00 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.86 |
| Forward P/E | 18.1 |
| Current P/E | 19.5 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 0.4% (minimal 5-day change). Below STRENGTH zone by 3.6pp (needs >4.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 57. Volume at 43% of 20MA suggests lack of conviction. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.38% (CS: 58) | Neutral |
| RSI_14 | 57.4 | Neutral |
| MACD Histogram | 0.44 | Bullish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 1.020x | Above |
| vs SMA200 | 0.898x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $186.97
- **Stop Loss:** $181.91 (2.7% risk)
- **Target:** $192.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 260
- **Position Value:** $48,612.20
- **Portfolio %:** 48.61%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-01-29 (Est: $1.97)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $1.85 | +4.1% |
| 2025Q2 | $2.66 | $2.72 | +2.1% |
| 2025Q1 | $3.00 | $3.06 | +2.1% |
| 2024Q4 | $1.76 | $1.87 | +6.0% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*